Bernhard Steiert

Title: Innovations by Bernhard Steiert in Anemia Treatment

Introduction

Bernhard Steiert is an accomplished inventor based in Freiburg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of anemia. His innovative work focuses on optimizing the dosage of erythropoiesis stimulating agents (ESA) for patients suffering from this condition.

Latest Patents

Steiert holds a patent for "Methods for the prediction of a personalized ESA-dose in the treatment of anemia." This invention features an integrative pharmacokinetic/pharmacodynamics (PK/PD) ESA-EpoR mathematical model that calculates the binding behavior of ESAs. The methods provided enable clinical practitioners to determine ESA binding sites in patients, which is crucial for optimizing treatment regimens, especially in cancer patients. The invention also includes methods for screening ESAs that exhibit higher specificity for cells expressing the EPO receptor, such as colony forming units-erythroid (CFU-E) cells.

Career Highlights

Throughout his career, Bernhard Steiert has worked with notable institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Albert-Ludwigs-University Freiburg. His work has been instrumental in advancing the understanding and treatment of anemia.

Collaborations

Steiert has collaborated with professionals such as Max Schelker and Marcel Schilling, contributing to the development of innovative solutions in the medical field.

Conclusion

Bernhard Steiert's contributions to anemia treatment through his patented methods demonstrate his commitment to improving patient care. His innovative approaches have the potential to significantly enhance the effectiveness of treatments for those affected by this condition.